Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 11 (2004), Issue 2, Pages 151-155
http://dx.doi.org/10.1155/2004/747841
Original Article

Long-Term Azithromycin Therapy in Cystic Fibrosis Patients: A Study on Drug Levels and Sputum Properties

Ulrich Baumann, Malcolm King, Ernst M App, Shusheng Tai, Armin König, Julia J Fischer, Torsten Zimmermann, Wolfgang Sextro, and Horst von der Hardt

1Department of Pediatric Pulmonology and Neonatology, Hanover Medical School, Hanover, Germany
2Pulmonary Research Group, University of Alberta, Edmonton, Alberta, Canada
3Cystic Fibrosis Outpatient Clinic, Department of Pneumology, University Hospital Freiburg, Freiburg, Germany
4Department of Chest Surgery, Hanover Medical School, Hanover, Germany
5Pfizer Pharmaceutical Group, R & D Illertissen, Illertissen, Germany
6Altona Pediatric Hospital, Hamburg, Germany

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ulrich Baumann, Malcolm King, Ernst M App, et al., “Long-Term Azithromycin Therapy in Cystic Fibrosis Patients: A Study on Drug Levels and Sputum Properties,” Canadian Respiratory Journal, vol. 11, no. 2, pp. 151-155, 2004. doi:10.1155/2004/747841